Multidrug-resistant Klebsiella pneumoniae: challenges for treatment, prevention and infection control

M Bassetti, E Righi, A Carnelutti… - Expert review of anti …, 2018 - Taylor & Francis
Introduction: Management of antimicrobial resistance in multi-drug-resistant-Klebsiella
pneumoniae (MDR-KP) is a major challenge for clinicians. The optimal treatment option for …

New advances in management and treatment of multidrug-resistant Klebsiella pneumoniae

A Russo, P Fusco, HL Morrone… - Expert Review of Anti …, 2023 - Taylor & Francis
Introduction The management of multidrug-resistant (MDR) Klebsiella pneumoniae (KP)
represents a major challenge in the field of infectious diseases. It is associated with a high …

Emerging high-risk ST101 and ST307 carbapenem-resistant Klebsiella pneumoniae clones from bloodstream infections in Southern Italy

D Loconsole, M Accogli, AL De Robertis… - Annals of Clinical …, 2020 - Springer
Abstract Background Carbapenem-resistant Klebsiella pneumoniae (CR-KP) is an urgent
public health issue in Italy. This pattern of resistance is due mainly to dissemination of …

High prevalence of carbapenem resistance and clonal expansion of blaNDM gene in Klebsiella pneumoniae isolates in an Iranian referral pediatric hospital

B Pourakbari, S Mamishi, S Poormohammadi… - Gut Pathogens, 2024 - Springer
Background The increasing global concern regarding antibiotic resistance necessitates in-
depth studies to comprehend the phenotypic and genotypic characteristics of resistant …

Characterization of Klebsiella pneumoniae Coproducing KPC and NDM-1 Carbapenemases from Turkey

A Tekeli, İ Dolapci, E Evren, E Oguzman… - Microbial Drug …, 2020 - liebertpub.com
Aims: The emergence of multidrug-resistant and carbapenem-resistant Klebsiella
pneumoniae has became a major public health threat. In this study, we describe the …

[HTML][HTML] Carbapenem Resistant Enterobacteriaceae

HZ Smith, B Kendall - 2019 - europepmc.org
Objectives: Select appropriate treatment options for a patient with carbapenem-resistant
Enterobacterales infections. Identify the reasons for a delayed diagnosis of carbapenem …

Preliminary phytochemical screening and in vitro antibacterial activity of Plumbago indica (Laal chitrak) root extracts against drug-resistant Escherichia coli and …

SF Bashir, G Kumar - Open Agriculture, 2021 - degruyter.com
Drug resistance is one of the problems affecting the world where drug-resistant Escherichia
coli and Klebsiella pneumoniae have been shown to be ubiquitous, frequently isolated from …

Risk factors for carbapenem-resistant Klebsiella pneumoniae infection and associated clinical outcomes

G Dai, Y Xu, H Kong, W **e… - American journal of …, 2021 - pmc.ncbi.nlm.nih.gov
Objective: To evaluate the risk factors and clinical outcomes of carbapenem-resistant
Klebsiella pneumoniae (K. pneumoniae)(CRKP) infection. Materials and Methods: A case …

Fecal Carriage and Epidemiology of Carbapenem-Resistant Enterobacteriaceae Among Hospitalized Patients in a University Hospital

Q Liu, L Liu, Y Li, X Chen, Q Yan… - Infection and drug …, 2019 - Taylor & Francis
Purpose To determine the prevalence and epidemiology of fecal carriage of carbapenem-
resistant Enterobacteriaceae (CRE), antimicrobial susceptibility, carbapenemase …

Novel Target Exploration from Hypothetical Proteins of Klebsiella pneumoniae MGH 78578 Reveals a Protein Involved in Host-Pathogen Interaction

G Pranavathiyani, J Prava, AC Rajeev… - Frontiers in Cellular and …, 2020 - frontiersin.org
The opportunistic pathogen Klebsiella pneumoniae is a causative agent of several hospital-
acquired infections. It has become resistant to a wide range of currently available antibiotics …